EcoDrugPlus

Ensembl ID : FBgn0030697
Gene Symbol: CG8565
9 External references
180 Possible Orthologues:

Ensembl ID : FBgn0031693
Gene Symbol: CYP4AC1
10 External references
242 Possible Orthologues:

Ensembl ID : FBgn0031694
Gene Symbol: CYP4AC2
9 External references
242 Possible Orthologues:

Ensembl ID : FBgn0031695
Gene Symbol: CYP4AC3
10 External references
242 Possible Orthologues:

Ensembl ID : FBgn0031925
Gene Symbol: CYP4D21
10 External references
242 Possible Orthologues:

Ensembl ID : FBgn0031976
Gene Symbol: CG7367
9 External references
112 Possible Orthologues:

Ensembl ID : FBgn0032973
Gene Symbol: CG6675
10 External references
124 Possible Orthologues:

Ensembl ID : FBgn0032987
Gene Symbol: RPL21
9 External references
108 Possible Orthologues:

Ensembl ID : FBgn0033058
Gene Symbol: CCHA2-R
10 External references
57 Possible Orthologues:

Ensembl ID : FBgn0033188
Gene Symbol: DRAT
10 External references
397 Possible Orthologues:

Ensembl ID : FBgn0033292
Gene Symbol: CYP4AD1
10 External references
240 Possible Orthologues:

Ensembl ID : FBgn0010052
Gene Symbol: JHE
10 External references
272 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).